Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
View in:
PubMed
subject areas
Adrenergic beta-Antagonists
Adrenergic beta-Antagonists
Aged
Aged
Angina Pectoris
Angina Pectoris
Benzimidazoles
Benzimidazoles
Calcium Channel Blockers
Calcium Channel Blockers
Chronic Disease
Chronic Disease
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Double-Blind Method
Double-Blind Method
Drug Synergism
Drug Synergism
Drug Therapy, Combination
Drug Therapy, Combination
Exercise Test
Exercise Test
Female
Female
Humans
Humans
Male
Male
Mibefradil
Mibefradil
Middle Aged
Middle Aged
Tetrahydronaphthalenes
Tetrahydronaphthalenes
Treatment Outcome
Treatment Outcome
Vasodilator Agents
Vasodilator Agents
authors with profiles
Udho Thadani